BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Katoch S, Sharma V, Patial V. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World J Gastroenterol 2022; 28(28): 3535-3554 [PMID: 36161051 DOI: 10.3748/wjg.v28.i28.3535]
URL: https://www.wjgnet.com/1007-9327/full/v28/i28/3535.htm
Number Citing Articles
1
Zhenshan Zhang, Leilei Wu, Juan Li, Jiayan Chen, Qi Yu, Hui Yao, Yaping Xu, Liang Liu. Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular CarcinomaJournal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03790-0
2
Vinesh Sharma, Vikram Patial. Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseasesFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991059
3
Ephraim E Parent, Amy M Fowler. Nuclear Receptor Imaging In Vivo—Clinical and Research AdvancesJournal of the Endocrine Society 2023; 7(3) doi: 10.1210/jendso/bvac197